Velcade and atrial fibrillation 
Velcade and atrial fibrillation Patient Reports February 11, 2012
Velcade Side Effects Report #4559249-X
Velcade side effect was reported by a Health Professional from on Jan 21, 2005. Male patient, 50 years of age, weighting 200.0 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cerebral haemorrhage, headache , lethargy, visual disturbance. Velcade dosage: 1.3 MG/M2 4 DAYS/ CYCLE INTRAVENOU. During the same period patient was treated with PLATELETS, OXYCONTIN, OXYCODONE PRN, CYCLOSPORINE, ACYCLOVIR. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5958358-8
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2008. Male patient, 79 years of age, weighting 155.2 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation
, chronic obstructive pulmonary disease, fall , hypotension, pneumonia , pulmonary embolism , sepsis , thrombocytopenia, urinary tract infection . Velcade dosage: 2 MG/M2, INTRAVENOUS. During the same period patient was treated with ALIMTA, ESCITALOPRAM, POTASSIUM, MIDODRINE HYDROCHLORIDE, ACETAMINOPHEN AND OXYCODONE, SPIRIVA, VITAMINS, ASPIRIN. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5989560-7
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 28, 2008. Male patient, 79 years of age, weighting 155.2 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: arteriosclerosis, atrial fibrillation
, fall , hypotension, pleural effusion, pneumonia , pulmonary embolism , sepsis , thrombocytopenia. Velcade dosage: 2MG/M2, INTRAVENOUS. During the same period patient was treated with ALIMTA, ESCITALOPRAM, POTASSIUM, MIDODRINE HYDROCHLORIDE, ACETAMINOPHEN AND OXYCODONE, SPIRIVA, VITAMINS, ASPRIN. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #6016927-3
Velcade side effect was reported by a Health Professional from UNITED STATES on Dec 11, 2008. Male patient, 79 years of age, weighting 155.2 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation
, chronic obstructive pulmonary disease, condition aggravated, fall , hypotension, lung infiltration, pleural effusion, pneumonia , pulmonary embolism . Velcade dosage: 2 MG/M2, INTRAVEOUS. During the same period patient was treated with ALIMTA, ESCITALOPRAM, POTASSIUM, MIDODRINE HYDROCHLORIDE, ACETAMINOPHEN AND OXYCODONE, SPIRIVA, VITAMINS, ASPIRIN. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5059155-0
Velcade side effect was reported by a Physician from UNITED STATES on July 05, 2006. Male patient, 70 years of age, weighting 158.1 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, alpha haemolytic streptococcal infection, atrial fibrillation
, blood glucose increased, blood ph increased, brain natriuretic peptide increased, bronchopneumonia, cardiac failure, cardiomegaly. Velcade dosage: 1.00 MG/M2, IV BOLUS. During the same period patient was treated with GEMCITABINE HYDROCHLORIDE, CARBOPLATIN, FERROUS SULPHATE, ROXICET, HYDROCHLOROTHIAZIDE, LIPITOR, PEPCID AC, ASPIRIN. Patient was hospitalized. Patient died on 07/07/2004.Velcade Side Effects Report #6090771-3
Velcade side effect was reported by a Physician from UNITED STATES on Feb 11, 2009. Male patient, 65 years of age, weighting 229.7 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: adhesion
, anaemia, atrial fibrillation , blood potassium increased, bronchial secretion retention, cardiac failure congestive, colitis, hypoalbuminaemia, hyponatraemia. Velcade dosage: 1 MG/M2. During the same period patient was treated with TAXOTERE, CARBOPLATIN, COUMADIN, CARDIZEM CD, HYDROCHLOROTHIAZIDE, LISINOPRIL. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #4804368-3
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 30, 2005. Female patient, 53 years of age, weighting 147.9 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: anxiety
, atrial fibrillation , atrial flutter, blood potassium decreased, constipation , deep vein thrombosis , depression , flank pain, heart rate increased. Velcade dosage: 1.60 MG/M2. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5285407-5
Velcade side effect was reported by a Physician from UNITED STATES on Mar 16, 2007. Female patient, 52 years of age, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, atrial fibrillation
, cardiac arrest , cardiac failure, cardiac procedure complication, oliguria, pneumonitis, post procedural complication, pulmonary hypertension . Velcade dosage: 0.30 MG/M2. During the same period patient was treated with TAXOL, CARBOPLATIN, CONJUGATED ESTROGENS, FLUOXETINE, NIFEDIPINE, OMEPRAZOLE, RISPERIDONE, TERBINAFINE. Patient was hospitalized. Patient died on 01/10/2005.Velcade Side Effects Report #5449557-2
Velcade side effect was reported by a Physician from UNITED STATES on Aug 27, 2007. Female patient, 52 years of age, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, atrial fibrillation
, cardiac output decreased, cardio-respiratory arrest, oliguria, pneumonitis, post procedural complication, pulmonary hypertension , respiratory failure. Velcade dosage: 0.30 MG/M2. During the same period patient was treated with TAXOL, CARBOPLATIN, CONJUGATED ESTROGENS, FLUOXETINE, NIFEDIPINE, OMEPRAZOLE, RISPERIDONE, TERBINAFINE. Patient was hospitalized. Patient died on 01/10/2005.Velcade Side Effects Report #4616765-X
Velcade side effect was reported by a Physician from on Dec 20, 2004. Male patient, 62 years of age, weighting 179.9 lb, was diagnosed with non-hodgkin's lymphoma stage iv and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Velcade dosage: unknown. Patient recovered.Velcade Side Effects Report #6026241-8
Velcade side effect was reported by a Physician from ITALY on Dec 17, 2008. Male patient, 75 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation
. Velcade dosage: 1.3 MG/M2, UNK, UNK. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #4780255-4
Velcade side effect was reported by a Health Professional from UNITED STATES on Sept 07, 2005. Male patient, 48 years of age, weighting 180.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation
, bile duct obstruction, catheter site cellulitis, diarrhoea, febrile neutropenia, hypokalaemia, hypomagnesaemia, hypotension. Velcade dosage: unknown. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, MORPHINE, PROPRANOLOL, REGLAN. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5453459-5
Velcade side effect was reported by a Health Professional from UNITED STATES on Sept 04, 2007. Male patient, 48 years of age, was diagnosed with neoplasm and was treated with Velcade. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, atrial fibrillation
, atrial flutter, dizziness , fall , head injury, hypotension, syncope. Velcade dosage: 1.30 MG/M2, UNK, IV BOLUS. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5054421-7
Velcade side effect was reported by a Physician from UNITED STATES on June 26, 2006. Male patient, 72 years of age, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, aortic aneurysm
, atrial fibrillation , blood lactic acid increased, haemodialysis, intestinal ischaemia, pneumonia , pneumonia bacterial. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE. Patient was hospitalized. Patient died on 04/30/2006.Velcade Side Effects Report #5130139-7
Velcade side effect was reported by a Physician from UNITED STATES on Oct 03, 2006. Male patient, 72 years of age, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain
, acute respiratory distress syndrome, aortic aneurysm , aortic arteriosclerosis, atrial fibrillation , autoimmune thyroiditis, band neutrophil count increased, band neutrophil percentage increased. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE. Patient was hospitalized. Patient died on 04/30/2006.Velcade Side Effects Report #5009148-4
Velcade side effect was reported by a Physician from UNITED STATES on May 01, 2006. Male patient, 72 years of age, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, atrial fibrillation
, blood lactic acid increased, haemodialysis, intestinal ischaemia, lung infiltration, pneumonia . Velcade dosage: 1.00 MG/M2 INTRAVENOUS. During the same period patient was treated with THALIDOMIDE. Patient was hospitalized. Patient died on 04/30/2006.Velcade Side Effects Report #5354877-6
Velcade side effect was reported by a Physician from UNITED STATES on May 31, 2007. Male patient, 71 years of age, weighting 183.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation
, blood creatinine increased, cellulitis , febrile neutropenia, groin abscess, groin pain, thrombocytopenia. Velcade dosage: 1.50 MG/M2, INTRAVENOUS. During the same period patient was treated with TYLENOL, CARVEDILOL, VICODIN, COLACE, DOXAZOSIN, ESOMEPRAZOLE, NITROGLYCERIN, HYDROXIDE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5334745-6
Velcade side effect was reported by a Physician from UNITED STATES on May 11, 2007. Female patient, 68 years of age, weighting 293.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspiration, asthma
, atrial fibrillation , cardiac failure congestive, catheter related complication, chronic obstructive pulmonary disease, confusional state, epistaxis, haematocrit decreased. Velcade dosage: 1.50 MG/M2, INTRAVENOUS. During the same period patient was treated with QUININE SULPHATE, BUMEX, ARIMIDEX, CELEBREX, LEVOXYL, PLAVIX, CATAPRESS, GLIPIZIDE. Patient was hospitalized. Patient died on 02/03/2007.Velcade Side Effects Report #6021809-7
Velcade side effect was reported by a Physician from UNITED STATES on Dec 15, 2008. Male patient, 86 years of age, weighting 168.0 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, aortic stenosis, aortic valve incompetence, atrial fibrillation , haematuria, pulmonary hypertension , tricuspid valve incompetence. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE, ASPIRIN, LYRICA, FLOMAX, EFFEXOR, LEVAQUIN, HYDRALAZINE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5341817-9
Velcade side effect was reported by a Physician from UNITED KINGDOM on May 18, 2007. Female patient, 84 years of age, weighting 100.5 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , gastrointestinal hypomotility, hyponatraemia, paraproteinaemia, pneumonia aspiration. Velcade dosage: 1.80 MG, UNK, INTRAVENOUS. During the same period patient was treated with AMLODIPINE, VALPROATE, CLODRONATE DI, VALSARTAN, IBUPROFEN, ORAMORPH. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #6026237-6
Velcade side effect was reported by a Physician from ITALY on Dec 18, 2008. Male patient, 84 years of age, weighting 172.0 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive. Velcade dosage: unknown. During the same period patient was treated with ALKERAN, THALIDOMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5214194-1
Velcade side effect was reported by a Physician from UNITED STATES on Jan 03, 2007. Male patient, 82 years of age, weighting 173.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, chronic obstructive pulmonary disease, hyperlipidaemia, mental status changes, multiple myeloma , pancytopenia, renal failure acute, respiratory failure. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, ASCORBIC ACID. Patient was hospitalized. Patient died on 11/18/2006.Velcade Side Effects Report #5266999-9
Velcade side effect was reported by a Physician from UNITED STATES on Mar 01, 2007. Male patient, 82 years of age, weighting 173.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, chronic obstructive pulmonary disease, condition aggravated, hyperlipidaemia, mental status changes, multiple myeloma , pancytopenia. Velcade dosage: 1.90 MG,INTRAVENOUS. During the same period patient was treated with MELPHALAN, ASCORBIC ACID, LASIX, MICRO, DURAGESIC, ZOFRAN, ZOMETA, PROCRIT. Patient was hospitalized. Patient died on 11/18/2006.Velcade Side Effects Report #5313481-6
Velcade side effect was reported by a Physician from SWITZERLAND on Apr 13, 2007. Female patient, 82 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , chest pain . Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient recovered.Velcade Side Effects Report #5126344-6
Velcade side effect was reported by a Physician from UNITED STATES on Sept 27, 2006. Female patient, 82 years of age, weighting 143.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , brain natriuretic peptide increased, diastolic dysfunction, fibrin d dimer increased, respiratory distress. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with ALTACE, DARVOCET, NEURONTIN, LORTAB, ASPIRIN. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5127196-0
Velcade side effect was reported by a Physician from UNITED STATES on Sept 27, 2006. Female patient, 82 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, asthenia, atrial fibrillation , diastolic dysfunction, flank pain, hypotension, lung infiltration, pneumonia , pneumonitis. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with BETAPACE, ALTACE, ASPIRIN, NEURONTIN, ZOLOFT, FOLIC ACID, DARVOCET. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5169030-9
Velcade side effect was reported by a Physician from UNITED STATES on Nov 21, 2006. Female patient, 82 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic valve disease, atrial fibrillation , blood potassium decreased, brain natriuretic peptide increased, cardiac failure congestive, dilatation atrial, hypotension, malignant hypertension, mitral valve incompetence. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with BETAPACE, ALTACE, ASPIRIN, NEURONTIN, ZOLOFT, FOLIC ACID, DARVOCET. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5169048-6
Velcade side effect was reported by a Physician from UNITED STATES on Nov 21, 2006. Female patient, 82 years of age, weighting 143.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, anaemia, aortic valve disease, asthenia, atrial fibrillation , atrial flutter, blood ph decreased, blood pressure increased, brain natriuretic peptide increased. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with ALTACE, DARVOCET, NEURONTIN, LORTAB, ASPIRIN. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5169057-7
Velcade side effect was reported by a Physician from UNITED STATES on Nov 21, 2006. Male patient, 82 years of age, weighting 173.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, chronic obstructive pulmonary disease, condition aggravated, hyperlipidaemia, mental status changes, multiple myeloma , pancytopenia, renal failure acute. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, ASCORBIC ACID. Patient was hospitalized. Patient died on 11/18/2006.Velcade Side Effects Report #5717249-8
Velcade side effect was reported by a Physician from UNITED STATES on Apr 14, 2008. Male patient, 81 years of age, weighting 179.9 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, atrial fibrillation , atrial flutter, atrioventricular block, chest pain , heart rate increased, hypotension, platelet count decreased. Velcade dosage: 1.00 MG/M2. During the same period patient was treated with REVLIMID, DEXAMETHASONE, ACYCLOVIR, BACTRIUM DS, FERRO, FLECAINIDE ACETATE, METOPROLOL TARTRATE, MYCELEX. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5104141-5
Velcade side effect was reported by a Physician from FRANCE on Aug 28, 2006. Female patient, 79 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure, lymphopenia, ventricular hypertrophy. Velcade dosage: 1.30 MG/M2, ; 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with LYTOS. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5657937-5
Velcade side effect was reported by a Physician from GERMANY on Feb 22, 2008. Female patient, 79 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac arrest , gastric haemorrhage, gastric ulcer, haematemesis, nausea , oesophageal candidiasis, oxygen saturation decreased. Velcade dosage: 1.75 MG, INTRAVENOUS. During the same period patient was treated with METOPROLOL SUCCINATE, PREDNISOLONE, TOREM, PANTOPRAZOLE, PASPERTIN, NOVAMIN, MIRTAZAPINE, GIGIMERCK. Patient died on 11/22/2007.Velcade Side Effects Report #5798850-2
Velcade side effect was reported by a Health Professional from FRANCE on June 19, 2008. Female patient, 79 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anuria, aplasia, atrial fibrillation , bradycardia, cardiac failure, hypotension, multi-organ failure, respiratory distress, sepsis . Velcade dosage: 2.1 MG, INTRAVENOUS. During the same period patient was treated with ONDANSETRON, OSTRAM, KARDEGIC, BISOPROLOL FUMARATE, COZAAR, FOSAMAX, ACETAMINOPHEN. Patient was hospitalized. Patient died on 05/14/2008.Velcade Side Effects Report #5261607-5
Velcade side effect was reported by a Physician from RUSSIAN FEDERATION on Feb 28, 2007. Female patient, 78 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation . Velcade dosage: 2.70 MG, INTRAVENOUS. Patient recovered.Velcade Side Effects Report #5398452-6
Velcade side effect was reported by a Physician from UNITED STATES on July 13, 2007. Female patient, 78 years of age, weighting 172.8 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atelectasis, atrial fibrillation , blood potassium decreased, blood pressure systolic decreased, brain natriuretic peptide increased, cardiac failure congestive, chronic obstructive pulmonary disease, coronary artery disease . Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with DOXIL, PALONOSETRON, DEXAMETHASONE, PROCHLORPERAZINE MALEATE, COMPAZINE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5513516-1
Velcade side effect was reported by a Physician from RUSSIAN FEDERATION on Nov 02, 2007. Female patient, 78 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , atrial flutter, chest pain , headache , heart rate increased. Velcade dosage: unknown. Patient recovered.Velcade Side Effects Report #4711309-6
Velcade side effect was reported by a Physician from UNITED STATES on June 23, 2005. Female patient, 78 years of age, weighting 151.2 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anorexia, atrial fibrillation , cardiac failure congestive, catheter site infection, clostridium colitis, dehydration, hypotension, laryngeal disorder, lung infection. Velcade dosage: 7.02 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DOXIL. Patient was hospitalized. Patient died on 06/01/2005.Velcade Side Effects Report #4736982-8
Velcade side effect was reported by a Physician from BELGIUM on July 19, 2005. Male patient, 78 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, akinesia, aortic valve incompetence, atrial fibrillation , atrial flutter, blood pressure decreased, cardiac arrest , cardiogenic shock, ejection fraction decreased. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with SOTALOL, CARDIO ASPIRINA, BACTRIMTE, CLOZAN, FENOFIBRATE, ARANESP, ZOMETA. Patient died.Velcade Side Effects Report #4778810-0
Velcade side effect was reported by a Physician from BELGIUM on Sept 09, 2005. Male patient, 78 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, akinesia, aortic valve incompetence, atrial fibrillation , atrial flutter, blood pressure decreased, cardiac arrest , cardiogenic shock, ejection fraction decreased. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with SOTALOL, CARDIO ASPIRINA, BACTRIMTE, CLOZAN, LIPANTHYL, ARANESP, ZOMETA. Patient died.Velcade Side Effects Report #5313482-8
Velcade side effect was reported by a Physician from ITALY on Apr 13, 2007. Female patient, 77 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation . Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, MELPHALAN, PREDNISONE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5641277-4
Velcade side effect was reported by a Physician from ITALY on Feb 15, 2008. Male patient, 77 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , electrocardiogram t wave inversion, syncope. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with THALOMID, ACETYLSALICYLIC ACID SRT, LANSOPRAZOLE, MELPHALAN, PREDNISONE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5691927-1
Velcade side effect was reported by a Physician from ITALY on Mar 19, 2008. Male patient, 77 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , electrocardiogram t wave inversion, syncope. Velcade dosage: unknown. During the same period patient was treated with THALIDOMIDE, MELPHALAN, PREDNISONE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5753074-X
Velcade side effect was reported by a Physician from ITALY on May 22, 2008. Male patient, 77 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , syncope. Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, ACETYLSALICYLIC ACID SRT, LANSOPRAZOLE, MELPHALAN, PREDNISONE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5203475-3
Velcade side effect was reported by a Physician from AUSTRALIA on Dec 27, 2006. Female patient, 76 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, atrial fibrillation , cardiac failure, condition aggravated, confusional state, constipation , diarrhoea, dyspnoea, fatigue. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, MS CONTIN. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5223230-8
Velcade side effect was reported by a Physician from AUSTRALIA on Jan 15, 2007. Female patient, 76 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , back pain , cardiac failure, confusional state, constipation , diarrhoea, dyspnoea, fatigue, mobility decreased. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, MS CONTIN, OMEPRAZOLE, PREDNISONE, FUROSEMIDE, HYDROCORTISONE, PROMETHAZINE HYDROCHLORIDE, ZOLEDRONIC ACID. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5549793-0
Velcade side effect was reported by a Physician from UNITED STATES on Nov 27, 2007. Male patient, 76 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , coronary artery disease , mitral valve stenosis, pneumonia . Velcade dosage: unknown. During the same period patient was treated with THALOMID, DEXAMETHASONE, LOVENOX, PROTONIX, CORTICOSTEROIDS. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5599224-X
Velcade side effect was reported by a Physician from UNITED STATES on Jan 10, 2008. Male patient, 76 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , coronary artery disease , mitral valve stenosis, pneumonia , stem cell transplant. Velcade dosage: 1.30 MG/M2,. During the same period patient was treated with THALOMID, DEXAMETHASONE, LOVENOX, PROTONIX, CORTICOSTEROIDS. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5648201-9
Velcade side effect was reported by a Physician from UNITED STATES on Feb 20, 2008. Male patient, 76 years of age, weighting 168.0 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic stenosis, aortic valve incompetence, atrial fibrillation , dizziness , haematuria, pulmonary hypertension , tricuspid valve incompetence. Velcade dosage: 1.30 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE, ASPIRIN, LYRICA, FLOMAX, EFFEXOR, LEVAQUIN, HYDRALAZINE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5705774-5
Velcade side effect was reported by a Physician from UNITED STATES on Mar 31, 2008. Male patient, 76 years of age, weighting 168.0 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, aortic valve incompetence, atrial fibrillation , haematuria, pulmonary hypertension , spinal laminectomy, tricuspid valve incompetence. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with MELPHALAN, PREDNISONE, ASPIRIN, LYRICA, FLOMAX, EFFEXOR, LEVAQUIN, HYDRALAZINE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5746703-8
Velcade side effect was reported by a Physician from JAPAN on May 08, 2008. Male patient, 76 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , urticaria. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with NORVASC, MICARDIS, GLUFAST, FAMOTIDINE, SEIBULE, MAGNESIUM OXIDE. Patient recovered.Velcade Side Effects Report #5809744-8
Velcade side effect was reported by a Physician from JAPAN on June 27, 2008. Male patient, 76 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , palpitations, urticaria. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with NORVASC, MICARDIS, GLUFAST, FAMOTIDINE, SEIBULE, MAGNESIUM OXIDE. Patient recovered.Velcade Side Effects Report #5872529-0
Velcade side effect was reported by a Physician from JAPAN on Aug 22, 2008. Male patient, 76 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , palpitations, urticaria. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with NORVASC, MICARDIS, GLUFAST, FAMOTIDINE, SEIBULE, MAGESIUM OXIDE. Patient recovered.Velcade Side Effects Report #6026222-4
Velcade side effect was reported by a Physician from SPAIN on Dec 17, 2008. Female patient, 76 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , transient ischaemic attack. Velcade dosage: 1.8 MG, INTRAVENOUS. During the same period patient was treated with PREDNISONE, THALIDOMIDE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #4591840-7
Velcade side effect was reported by a Health Professional from on Feb 04, 2005. Male patient, 76 years of age, weighting 188.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, asthenia, atelectasis, atrial fibrillation , blood glucose increased, brain natriuretic peptide increased, cardiomegaly, epistaxis, fluid overload. Velcade dosage: unknown. During the same period patient was treated with AREDIA, ZOLEDRONIC ACID, ALLOPURINOL, ACETAMINOPHEN, DIHPHENDRAMINE HYDROCHLORIDE, AMLODIPINE BESYLATE, VITAMINS. Patient was hospitalized. Patient died.Velcade Side Effects Report #4799100-6
Velcade side effect was reported by a Physician from POLAND on Sept 27, 2005. Male patient, 76 years of age, weighting 201.9 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alveolitis allergic, angioneurotic oedema, atrial fibrillation , blood glucose increased, cardiac failure, dehydration, diarrhoea, face injury. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with PREDNISONE, MELPHALAN, CAPTOPRIL, XARTAN, BISOCARD, ACARD, KETONAL, OMEPRAZOLE. Patient was hospitalized. Patient died on 07/28/2005.Velcade Side Effects Report #4944199-7
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 21, 2006. Male patient, 76 years of age, weighting 188.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, asthenia, atelectasis, atrial fibrillation , bacterial infection , blood magnesium decreased, cardiomegaly, cough, dyspnoea. Velcade dosage: 3.30 MG, INTRAVENOUS. During the same period patient was treated with AREDIA, ZOLEDRONIC ACID, ALLOPURINOL, EXTRA STRENGTH TYLENOL, DIPHENHYDRAMINE, NORVASC, VITAMINS. Patient was hospitalized. Patient died on 01/17/2005.Velcade Side Effects Report #5376304-5
Velcade side effect was reported by a Physician from ITALY on June 18, 2007. Male patient, 75 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation . Velcade dosage: 1.30 MG/M2. Patient recovered.Velcade Side Effects Report #4907779-0
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Jan 24, 2006. Female patient, 75 years of age, weighting 139.8 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , cardiac enzymes increased, condition aggravated, diarrhoea, fluid overload, haematemesis, hypothermia , melaena. Velcade dosage: 2.10 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with CLODRONATE DI, ALLOPURINOL, AMLODIPINE, LOPERAMIDE, METRONIDAZOLE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #4961052-3
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Mar 13, 2006. Female patient, 75 years of age, weighting 139.8 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , cardiac enzymes increased, diarrhoea, fluid overload, haematemesis, hypothermia , melaena, rectal haemorrhage. Velcade dosage: 2.10 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with CLODRONATE DI, ALLOPURINOL, AMLODIPINE, LOPERAMIDE, METRONIDAZOLE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #4989188-1
Velcade side effect was reported by a Physician from UNITED STATES on Jan 11, 2006. Female patient, 74 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , dehydration, pneumonia . Velcade dosage: 1.30 MG/M2,. During the same period patient was treated with ALBUTEROL. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5383585-0
Velcade side effect was reported by a Physician from SPAIN on June 25, 2007. Male patient, 73 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: aortic valve incompetence, atrial fibrillation , cardiac failure. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with MELPHALAN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5599291-3
Velcade side effect was reported by a Physician from SPAIN on Jan 09, 2008. Female patient, 73 years of age, weighting 132.7 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , dyspnoea, hepatomegaly, oedema peripheral, upper respiratory tract infection, viral infection . Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5843412-1
Velcade side effect was reported by a Physician from SPAIN on July 30, 2008. Female patient, 73 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, dyspnoea, hepatomegaly, oedema peripheral, tachyarrhythmia, viral upper respiratory tract infection. Velcade dosage: 1.3 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5872852-X
Velcade side effect was reported by a Physician from UNITED STATES on Aug 22, 2008. Male patient, 73 years of age, weighting 183.0 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , myelodysplastic syndrome, neutropenic sepsis. Velcade dosage: 1.9 MG, UNK, IV BOLUS. During the same period patient was treated with THALIDOMIDE, VALTREX, LYRICA, LIPITOR, AMIODARONE, LASIX. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5908992-6
Velcade side effect was reported by a Physician from SPAIN on Sept 22, 2008. Male patient, 73 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , disease progression, hypotension, tachycardia. Velcade dosage: 2.2 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.Velcade Side Effects Report #5917452-8
Velcade side effect was reported by a Physician from SPAIN on Sept 29, 2008. Male patient, 73 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , bradycardia, disease progression, hypotension, tachycardia. Velcade dosage: 2.2 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.Velcade Side Effects Report #5933718-X
Velcade side effect was reported by a Physician from SPAIN on Oct 15, 2008. Male patient, 73 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , bradycardia, disease progression, hypotension, no therapeutic response, tachycardia. Velcade dosage: 2.2 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, PREDNISONE, DIGOXIN, VALSARTAN, VERAPAMIL. Patient was hospitalized and became disabled. Patient recovered.Velcade Side Effects Report #6055353-8
Velcade side effect was reported by a Physician from UNITED STATES on Jan 14, 2009. Male patient, 73 years of age, weighting 231.9 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cellulitis , international normalised ratio abnormal, renal failure acute, wheelchair user. Velcade dosage: 1.3 MG/M2, IV BOLUS. During the same period patient was treated with DEXAMETHASONE, POTASSIUM CHLORIDE, COUMADIN, FUROSEMIDE, ENALAPRIL MALEATE, OLMESARTAN MEDOXOMIL, GLUCOPHAGE, COREG. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #6111536-X
Velcade side effect was reported by a Physician from ITALY on Feb 25, 2009. Female patient, 73 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, atrial fibrillation , blood lactate dehydrogenase increased. Velcade dosage: 2.23 MG. During the same period patient was treated with DEXAMETHASONE, METOPROLOL TARTRATE, EUTIROX, ZANTAC, TRAMADOL, CARDIOASPRIN. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #6125896-7
Velcade side effect was reported by a Physician from ITALY on Mar 08, 2009. Female patient, 73 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, atrial fibrillation , blood lactate dehydrogenase increased, cardiac disorder, muscle disorder . Velcade dosage: 2.2 MG,. During the same period patient was treated with DEXAMETHASONE, METOPROLOL TARTRATE, EUTIROX, ZANTAC, TRAMADOL, ASPIRIN. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5236692-7
Velcade side effect was reported by a Physician from BRAZIL on Jan 30, 2007. Male patient, 72 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , atrioventricular block, ejection fraction decreased, lung infiltration, sepsis , urinary tract infection . Velcade dosage: unknown. During the same period patient was treated with TYLEX, OMEPRAZOLE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5804271-6
Velcade side effect was reported by a Physician from IRELAND on June 25, 2008. Female patient, 72 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive. Velcade dosage: 1.6 MG//M2, INTRAVENOUS. During the same period patient was treated with CRESTOR, MOVICOL, MOTILIUM, ACETAMINOPHEN, DEFENE, SOLPADEINE, NORMISON. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5827095-2
Velcade side effect was reported by a Physician from IRELAND on July 14, 2008. Female patient, 72 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, pain . Velcade dosage: 1.5 MG/M2, INTRAVENOUS. During the same period patient was treated with CRESTOR, MOVICOL, MOTILIUM, ACETAMINOPHEN, DICLOFENAC, SOLPADEINE, NORMISON. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5872530-7
Velcade side effect was reported by a Physician from IRELAND on Aug 18, 2008. Female patient, 72 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, pain . Velcade dosage: 1.6 MG/M2, INTRAVENOUS. During the same period patient was treated with CRESTOR, MOVICOL, MOTILIUM, ACETAMINOPHEN, DIFINE, SOLPADEINE, NORMISON. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5894992-1
Velcade side effect was reported by a Physician from IRELAND on Sept 11, 2008. Female patient, 72 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure congestive, chest pain . Velcade dosage: 1.6 MG/M2, INTRAVENOUS. During the same period patient was treated with CRESTOR, MOVICOL, MOTILIUM, ACETAMINOPHEN, DICLOFENAC, SOLPADEINE, NORMISON. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5334743-2
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on May 07, 2007. Male patient, 71 years of age, weighting 160.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , diarrhoea, disturbance in attention, hypoaesthesia, hypogeusia, hyposmia, neuropathy, somnolence, ventricular tachycardia. Velcade dosage: unknown. During the same period patient was treated with ZOMETA, ACYCLOVIR, NORVASC, ALLEGRA, DIFLUCAN, PANTOPRAZOLE, TOPROL. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5368126-6
Velcade side effect was reported by a Physician from JAPAN on June 06, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, hypovolaemia, platelet count decreased, pleural effusion, pyrexia, rash . Velcade dosage: 2.20 MG,. During the same period patient was treated with PREDNISOLONE, ITRACONAZOLE, ALLOPURINOL, MUCOSTA, ZANTAC, BICARBONATE IN PLASTIC CONTAINER, ADOFEED, LOXONIN. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5376670-0
Velcade side effect was reported by a Physician from ITALY on June 18, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure. Velcade dosage: 1.30 MG/M2. Patient recovered.Velcade Side Effects Report #5165805-0
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2006. Male patient, 71 years of age, weighting 160.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , diarrhoea, disturbance in attention, hypoaesthesia, hypogeusia, hyposmia, neuropathy, somnolence, ventricular tachycardia. Velcade dosage: unknown. During the same period patient was treated with ZOMETA, ACYCLOVIR, NORVASC, ALLEGRA, DIFLUCAN, PANTOPRAZOLE, TOPROL. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5393053-8
Velcade side effect was reported by a Physician from ITALY on July 09, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: activities of daily living impaired, acute pulmonary oedema, anaemia, atrial fibrillation , cardiac failure, discomfort. Velcade dosage: 1.30 MG/M2. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5466070-7
Velcade side effect was reported by a Physician from JAPAN on Sept 07, 2007. Male patient, 71 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, disease progression, hypovolaemia, lymphocyte count decreased, platelet count decreased, pleural effusion. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, ITRACONAZOLE, ALLOPURINOL, MUCOSTA, ZANTAC, BICARBONATE IN PLASTIC CONTAINER, ADOFEED, LOXONIN. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5485964-X
Velcade side effect was reported by a Physician from JAPAN on Oct 01, 2007. Male patient, 71 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma
, prophylaxis and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, disease progression, hypovolaemia, lymphocyte count decreased, platelet count decreased, pleural effusion. Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with BAKTAR, PREDNISOLONE, ITRACONAZOLE, ALLOPURINOL, MUCOSTA, ZANTAC, BICARBONATE IN PLASTIC CONTAINER, ADOFEED. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5489257-6
Velcade side effect was reported by a Physician from UNITED STATES on Oct 05, 2007. Female patient, 71 years of age, weighting 133.8 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , bacteraemia, cholelithiasis, enteritis, enterococcal infection, hypokalaemia, hypotension, metabolic acidosis. Velcade dosage: 1.00 MG/M2. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5517833-0
Velcade side effect was reported by a Physician from UNITED STATES on Nov 02, 2007. Female patient, 71 years of age, weighting 133.8 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , bacteraemia, cholelithiasis, diarrhoea, enteritis, hypokalaemia, hypotension, metabolic acidosis. Velcade dosage: 1.00 MG/M2 ; 1.00 MG/M2. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5679631-7
Velcade side effect was reported by a Physician from JAPAN on Mar 12, 2008. Male patient, 71 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma
, prophylaxis and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood lactate dehydrogenase increased, c-reactive protein increased, diarrhoea, disease progression, platelet count decreased, pleural effusion, pyrexia, rash . Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM, PREDNISOLONE, ITRACONAZOLE, ALLOPURINOL, MUCOSTA, ZANTAC, BICARBONATE IN PLASTIC CONTAINER, ADOFEED. Patient was hospitalized. Patient died on 08/23/2007.Velcade Side Effects Report #6026243-1
Velcade side effect was reported by a Physician from ITALY on Dec 17, 2008. Male patient, 71 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure. Velcade dosage: 1.3 MG/M2. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #4881252-0
Velcade side effect was reported by a Physician from UNITED STATES on Oct 17, 2005. Male patient, 71 years of age, weighting 134.3 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , clostridial infection, dehydration, hyponatraemia, hypotension, nausea . Velcade dosage: 4.60 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with DOXIL. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #4988320-3
Velcade side effect was reported by a Physician from FRANCE on Apr 12, 2006. Female patient, 71 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with PROPRANOLOL. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5086030-8
Velcade side effect was reported by a Physician from AUSTRALIA on Aug 08, 2006. Male patient, 70 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , bradycardia, sick sinus syndrome, viral infection . Velcade dosage: unknown. During the same period patient was treated with CALTRATE, BICARBONATE IN PLASTIC CONTAINER, DIAMICRON, AUGMENTIN DUOTE, FUROSEMIDE, WARFARIN, ISOPTIN, TEARS PLUS. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5391773-2
Velcade side effect was reported by a Physician from SWEDEN on July 05, 2007. Male patient, 70 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , bradycardia, bronchitis chronic, presyncope. Velcade dosage: 3.50 MG, INTRAVENOUS. During the same period patient was treated with SPIRIVA, CRESTOR, METOPROLOL TARTRATE, WARFARIN, PRILOSEC, PLENDIL. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5844830-8
Velcade side effect was reported by a Physician from SWEDEN on July 30, 2008. Male patient, 70 years of age, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , bradycardia, bronchitis chronic, presyncope. Velcade dosage: 3.50 MG, INTRAVENOUS. During the same period patient was treated with SPIRIVA, CRESTOR, METOPROLOL TARTRATE, WARFARIN, OMEPRAZOLE, PLENDIL, SYMBICORT TURBUHALER, ALVEDON. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #6053896-4
Velcade side effect was reported by a Physician from UNITED KINGDOM on Jan 15, 2009. Female patient, 70 years of age, weighting 208.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , dizziness , dyspnoea, malaise. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FRUSEMIDE, ATENOLOL. Patient recovered.Velcade Side Effects Report #6066101-X
Velcade side effect was reported by a Physician from UNITED KINGDOM on Jan 22, 2009. Female patient, 70 years of age, weighting 208.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation . Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FRUSEMIDE, ATENOLOL, ENALAPRIL MALEATE, FLUTICASONE PROPIONATE, BENDROFLUAZIDE, FUROSEMIDE. Patient recovered.Velcade Side Effects Report #6111524-3
Velcade side effect was reported by a Physician from UNITED KINGDOM on Feb 19, 2009. Female patient, 70 years of age, weighting 208.1 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation . Velcade dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FRUSEMIE, ATENOLOL, ENALAPRIL MALEATE, FLUTICASONE PROPIONATE, BENDROFLUAZIDE. Patient recovered.Velcade Side Effects Report #5218967-0
Velcade side effect was reported by a Physician from UNITED STATES on Jan 08, 2007. Male patient, 68 years of age, weighting 174.2 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: alcohol use, atrial fibrillation . Velcade dosage: unknown. During the same period patient was treated with REVLIMID, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #5384354-8
Velcade side effect was reported by a Physician from UNITED STATES on Feb 16, 2007. Female patient, 68 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , deep vein thrombosis , hypokalaemia, hypomagnesaemia, pleurisy, pneumonia , pulmonary embolism , pulmonary oedema, pyrexia. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with FUROSEMIDE, COREG, TRAZODONE, ALENDRONATE, COLACE, SENNA, COUMADIN, PRILOSEC. Patient was hospitalized. Patient recovered.Velcade Side Effects Report #4766349-8
Velcade side effect was reported by a Physician from BULGARIA on Aug 26, 2005. Male patient, 68 years of age, weighting 198.4 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , blood calcium decreased, blood potassium increased, cardiac failure, hepatic failure, hepatomegaly, pneumonitis, splenomegaly. Velcade dosage: 2.60 MG, 2/WEEK, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 08/03/2005.Velcade Side Effects Report #4899182-7
Velcade side effect was reported by a Physician from BULGARIA on Jan 16, 2006. Male patient, 68 years of age, weighting 198.4 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anorexia, aortic arteriosclerosis, atrial fibrillation , blood albumin decreased, blood calcium abnormal, blood potassium increased, bronchopneumonia, cardiac failure. Velcade dosage: 2.60 MG, 2/WEEK, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 08/03/2005.Velcade Side Effects Report #4948407-8
Velcade side effect was reported by a Physician from BULGARIA on Feb 24, 2006. Male patient, 68 years of age, weighting 198.4 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anorexia, aortic arteriosclerosis, aortic calcification, atrial fibrillation , bronchopneumonia, cardiac failure, cardiomyopathy , dilatation ventricular. Velcade dosage: 2.60 MG, 2/WEEK, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 08/03/2005.Velcade Side Effects Report #4999839-3
Velcade side effect was reported by a Physician from BULGARIA on Apr 28, 2006. Male patient, 68 years of age, weighting 198.4 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anorexia, aortic arteriosclerosis, aortic calcification, atrial fibrillation , blood albumin decreased, blood calcium decreased, blood potassium increased, bronchopneumonia. Velcade dosage: 2.60 MG, 2/WEEK, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 08/03/2005.Velcade Side Effects Report #5031183-0
Velcade side effect was reported by a Physician from BULGARIA on May 31, 2006. Male patient, 68 years of age, weighting 198.4 lb, was diagnosed with multiple myeloma
and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aortic arteriosclerosis, aortic calcification, atrial fibrillation , bronchopneumonia, cardiac failure, dilatation ventricular, hepatic failure, hepatomegaly. Velcade dosage: 2.60 MG, INTRAVENOUS. Patient was hospitalized and became disabled. Patient died on 08/03/2005.